Національний Медичний Університет Імені О.О. Богомольця
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Національний Медичний Університет Імені О.О. БогомольцяfiledCriticalНаціональний Медичний Університет Імені О.О. Богомольця
Priority to UAU201508206UpriorityCriticalpatent/UA105484U/en
Publication of UA105484UpublicationCriticalpatent/UA105484U/en
The method for instrumental membrane filtration plasmapheresis includes administration of heparin. On the day of the procedure of plasmapheresis, hematocrit in the blood is measured. Depending on the values obtained, in 15 minutes preceding the surgery systemic heparin administration is provided according to the following scheme: 50 U/kg when hematocrit is 35-40 %, 80 U/kg when hematocrit is 41-49 %, 100 U/kg when hematocrit is 50 % and above. Then plasmapheresis follows with subsequent intraoperative administration of the absolute anticoagulant into extracorporeal circuit according to the standard procedure.
UAU201508206U2015-08-192015-08-19Method for instrumental membrane filtration plasmapheresis
UA105484U
(en)
G-csf for use in treating or preventing a disease associated with aging in a patient, for administration with a stem-cell containing composition and/or an electromagnetic signal
PHARMACEUTICAL COMPOSITION CONTAINING PLASMA ENRICHED BY PLATFORM AND INTENDED FOR PREVENTION OR TREATMENT OF NEURO-SENSOR Hearing Aid or Noise in the Ears, and METHOD
Effects of normovolemic hemodilution with hetastarch starch 130/0.4 and electrolyte solution on blood coagulation during resection for liver cancer in elderly patients